Schedule 13G ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K309

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,111,049
Percent of class
5.4900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001389932-24-000008
Form type
SC 13G
Filer
DAFNA Capital Management LLC
CIK
CIK 1389933
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub